“third-rock-ventures” Archives

in
Entry Author Date Location
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More 09/13/19 National
The Winners of the 2019 Xconomy Awards Boston Are… 09/12/19 Boston
New BC Biotech Chinook Reels in $65M to Tackle Kidney Disease 08/22/19 National
Mark Levin Named Xconomy’s 2019 Lifetime Achievement Award Winner in Boston 07/31/19 National
After Amgen’s Spark, Revolution Med Nabs $100M to Push RAS Cancer Drugs 07/09/19 San Francisco
With $45M Nurix Deal, Gilead Enters Crowded Protein Degradation Field 06/19/19 San Francisco
Bio Roundup: ASCO Wrap, Bluebird’s EU Tap, CRISPR Baby Risk & More 06/07/19 National
To Catch Early Cancer, and Rivals, Thrive Banks on Hopkins Blood Test 05/30/19 Boston
Bio Roundup: Rare Disease Showdowns, Prices on TV, Dealmania & More 05/10/19 National
Goldfinch Bio Lands $55M From Gilead in Kidney Drug R&D Pact 05/08/19 Boston
Insitro Lands Three-Year Deal With Gilead to Find New NASH Drugs 04/16/19 National
The Life, Troubles, and Celgene Legacy of Deal Guru George Golumbeski 03/11/19 National
SPECIAL REPORT: 2019 Biopharma Outlook – Facing an Uncertain Future 03/01/19 National
MyoKardia Goes Solo as Sanofi Ends Precision Heart Drug Deal 01/02/19 San Francisco
Eyeing $500M, Moderna Outlines Plans for Biotech’s Biggest IPO Ever 11/09/18 Boston
Catch CRISPR 2.0, RNA-Targeting Drugs & More At “Disruptors” on Oct. 17 09/26/18 Boston
Agenda Posted for Boston’s Life Science Disruptors on Oct. 17 09/10/18 Boston
Working with Patients and a Fresh $80M, Fulcrum Eyes a 2019 IPO 09/05/18 Boston
Beam, Celsius & Arrakis at Boston’s Life Science Disruptors Oct. 17 08/27/18 Boston
Creating Companies Before 35: Meet the Young Innovator Award Finalists 08/08/18 Boston
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future? 08/08/18 San Francisco
Pliant Picks Up $62M to Test Lung, Liver Fibrosis Drug in the Clinic 07/16/18 San Francisco
Decibel Hauls in $55M to Bring Multiple Hearing Drugs to the Clinic 06/19/18 Boston
Langer, Yancopoulos & Hockfield to Headline Xcelerate at Biotech Week Boston 06/07/18 Boston
Celsius Snags $65M to Harness Single-Cell Genomics for Drug Discovery 05/15/18 Boston
Moderna’s Billions: Will Building Big Before an IPO Pay Off? 05/09/18 Boston
With $59M, Casma and Ex-Constellation CEO Take Aim at Cellular Trash 05/03/18 Boston
Third Rock’s Cedilla Launches with $56M for Protein Stability Drugs 04/24/18 Boston
Raising $56M, Revolution Medicines Drops Old Work and Turns to Cancer 04/24/18 San Francisco
Rheos Medicines Launches, Backed by $60M for Immunometabolism R&D 03/22/18 Boston
Page 1 of 17 next page »